# Yuriko Minami

> Yuriko Minami is a Series A investor backing Medical, Biotechnology and SNS. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 6
- Last investment: May 2026
- Lead investor: 17%
- Last updated: Aug 2026

Yuriko Minami is a Series A investor focused on Medical and Biotechnology. Yuriko Minami is the Capitalist at Mirai Sozo Organization.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3M–$4.7M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 33% |
| Biotechnology | 2 | 33% |
| SNS | 1 | 17% |
| Apps | 1 | 17% |
| Content | 1 | 17% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 33% |
| Seed | 1 | 17% |
| Pre-Seed | 1 | 17% |
| Series B | 1 | 17% |
| Series D | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Varinos | Varinos is a clinical laboratory contract analysis company that is a partner of medical institutions. Varinos provides genomic testing development and contract analysis services using the latest technology, the next-generation sequencer. | $7.9M | Series D | May 12, 2026 |  |
| Metagen Therapeutics | Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $15.7M | Series B | Sep 08, 2025 |  |
| ARCS | ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology. | $3.4M | Seed | Jan 20, 2025 |  |
| digzyme | Digzyme develops new enzymatic processes using bioinformatics. The company automates various stages of analysis related to the development of enzymes and bioprocesses using their core bioinformatics technology and further optimize using accumulated data. | $4.7M | Series A | Apr 23, 2024 |  |
| A10 Lab | A10 Lab is a company that aims to make people happy with technology that is independent of Sony's new business creation program. It provides Google Play with an app that allows users to do things that they have never been able to do with the custom app 'Min Chale' selected for two consecutive years. It is a company that bringsprofits to companies by improving lifetime value sales through the habitation of users that companies have. | $3M | Series A | Jan 22, 2024 |  |
| ARCS | ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology. | $522K | Pre-Seed | Apr 24, 2023 |  |

6 of 6 investments shown.

## Co-investors
- [Fast Track Initiative, Inc.](https://shizune.co/investors/profile/fast-track-initiative) — VC Fund, 4 deals together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 4 deals together
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund, 3 deals together
- [Deepcore](https://shizune.co/investors/profile/deepcore) — VC Fund, 2 deals together
- [DG Daiwa Ventures](https://shizune.co/investors/profile/dg-daiwa-ventures-6537) — VC Fund, 2 deals together
- [HERO Impact Capital](https://shizune.co/investors/profile/hero-impact-capital) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Angel Investors in Japan](https://shizune.co/investors/biotechnology-angel-investors-japan)
- [Biotech Angel Investors in Japan](https://shizune.co/investors/biotech-angel-investors-japan)
- [Biotechnology Angel Investors in Asia](https://shizune.co/investors/biotechnology-angel-investors-asia)
- [Life Science Investors in Japan](https://shizune.co/investors/life-science-investors-japan)

## FAQ

### What does Yuriko Minami invest in?

Yuriko Minami invests primarily in Medical, Biotechnology and SNS startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Yuriko Minami's check size?

Yuriko Minami typically joins rounds of $3M–$4.7M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yuriko Minami participates in.

### When did Yuriko Minami last invest?

The most recent investment recorded for Yuriko Minami closed in May 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co